Zobrazeno 1 - 7
of 7
pro vyhledávání: '"W. Shea Wright"'
Publikováno v:
ACS Omega, Vol 3, Iss 12, Pp 16882-16891 (2018)
Externí odkaz:
https://doaj.org/article/7f26a6f55e0c436da0a3049a36d17b3d
Autor:
Ian J. Stewart, Megan E. Amuan, Chen-Pin Wang, Eamonn Kennedy, Kimbra Kenney, J. Kent Werner, Kathleen F. Carlson, David F. Tate, Terri K. Pogoda, Clara E. Dismuke-Greer, W. Shea Wright, Elisabeth A. Wilde, Mary Jo Pugh
Publikováno v:
JAMA Neurol
ImportanceTraumatic brain injury (TBI) was common among US service members deployed to Iraq and Afghanistan. Although there is some evidence to suggest that TBI increases the risk of cardiovascular disease (CVD), prior reports were predominantly limi
Publikováno v:
ACS Omega, Vol 3, Iss 12, Pp 16882-16891 (2018)
ACS Omega
ACS Omega
Serum antibodies that recognize carbohydrate antigens play a fundamental role in immune defense, homeostasis, and autoimmunity. In addition, they serve as potential biomarkers for a variety of medical applications. For most anti-glycan antibodies fou
Autor:
Nigel Garrett, Jeffrey C. Gildersleeve, Sudipa Chowdhury, Penny L. Moore, W. Shea Wright, Lynn Morris, Quarraisha Abdool Karim, Salim S. Abdool Karim, Cathrine Scheepers, Christopher T. Campbell
Publikováno v:
AIDS. 31:2199-2209
Background The HIV-1 envelope is covered with glycans that provide structural integrity and protect conserved regions from host antibody responses. However, these glycans are often the target of broadly neutralizing antibodies (bNAbs) that emerge in
Autor:
W. Shea Wright, Ramiro L. Gutierrez, Alexander J. Polino, Barbara DeNearing, Pardeep Kumar, Brunda Tumala, Alaullah Sheikh, Clayton Harro, Jennifer Foulke-Abel, Jeffrey C. Gildersleeve, Srikanth Santhanam, Michael G. Prouty, David A. Sack, A. Louis Bourgeois, Matthew A. Ciorba, F. Matthew Kuhlmann, Chad K. Porter, Mark S. Riddle, James M. Fleckenstein, Subhra Chakraborty, Tim J. Vickers, Mark Donowitz
Publikováno v:
The Journal of clinical investigation. 128(8)
Enterotoxigenic Escherichia coli (ETEC) infections are highly prevalent in developing countries, where clinical presentations range from asymptomatic colonization to severe cholera-like illness. The molecular basis for these varied presentations, whi
Autor:
Jeffrey C. Gildersleeve, W. Shea Wright, Dean E. Brenner, Judson R. Mead, James W. Stave, Jung-hyun Rho, Paul D. Lampe
Publikováno v:
Journal of Proteomics. 96:291-299
We report on a high-dimensional method to globally profile glycoproteins that are modified with sialyl Lewis A or Lewis X glycans. Specifically, glycoproteins in serum or plasma are fractionated on a high-density antibody microarray (i.e., each are l
Autor:
Zhaojun Yin, Xuefei Huang, Katarzyna Kaczanowska, Philip Bentley, M. G. Finn, Sudipa Chowdhury, Claire Baniel, W. Shea Wright, Jeffrey C. Gildersleeve, Craig S. McKay, Lbachir BenMohamed
Publikováno v:
Yin, Zhaojun; Chowdhury, Sudipa; McKay, Craig; Baniel, Claire; Wright, W. Shea; Bentley, Philip; et al.(2015). Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine. ACS Chemical Biology, 10(10), 2364-2372. doi: 10.1021/acschembio.5b00406. UC Irvine: Institute for Clinical and Translational Science. Retrieved from: http://www.escholarship.org/uc/item/8hx3581s
Yin, Zhaojun; Chowdhury, Sudipa; McKay, Craig; Baniel, Claire; Wright, W. Shea; Bentley, Philip; et al.(2015). Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine. ACS Chemical Biology, 10(10), 2364-2372. doi: 10.1021/acschembio.5b00406. UC Irvine: Institute for Clinical and Translational Science. Retrieved from: http://www.escholarship.org/uc/item/6sx056fq
Yin, Zhaojun; Chowdhury, Sudipa; McKay, Craig; Baniel, Claire; Wright, W. Shea; Bentley, Philip; et al.(2015). Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine. ACS Chemical Biology, 10(10), 2364-2372. doi: 10.1021/acschembio.5b00406. UC Irvine: Institute for Clinical and Translational Science. Retrieved from: http://www.escholarship.org/uc/item/6sx056fq
Development of an effective vaccine targeting tumor associated carbohydrate antigens (TACAs) is an appealing approach toward tumor immunotherapy. While much emphasis has been typically placed on generating high antibody titers against the immunizing